Word

MYRUSPA

Status

Registered

Status Code

700

Status Date

Tuesday, August 13, 2019

Serial Number

88299383

Registration Number

5834785

Registration Date

Tuesday, August 13, 2019

Mark Type

4000

Filing Date

Wednesday, February 13, 2019

Published for Opposition

Tuesday, May 28, 2019

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events

Jul 5, 2023

Teas Change Of Correspondence Received

Jul 5, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Jul 5, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jul 5, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Jul 5, 2023

Teas Change Of Owner Address Received

Nov 8, 2022

Teas Change Of Correspondence Received

Nov 8, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 8, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Aug 13, 2019

Registered-Principal Register

May 28, 2019

Official Gazette Publication Confirmation E-Mailed

May 28, 2019

Published For Opposition

May 8, 2019

Notification Of Notice Of Publication E-Mailed

Apr 23, 2019

Approved For Pub - Principal Register

Apr 23, 2019

Assigned To Examiner

Mar 6, 2019

New Application Office Supplied Data Entered

Feb 16, 2019

New Application Entered